Filing Details

Accession Number:
0001567619-22-009698
Form Type:
4
Zero Holdings:
No
Publication Time:
2022-05-06 17:14:07
Reporting Period:
2021-10-15
Accepted Time:
2022-05-06 17:14:07
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1509261 Rezolute Inc. RZLT Pharmaceutical Preparations (2834) 273440894
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1755074 Wladimir Hogenhuis C/O Rezolute, Inc.
201 Redwood Shores Parkway, Suite 315
Redwood City CA 94065
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-10-15 7,693 $6.50 7,693 No 4 P Direct
Common Stock Acquisiton 2022-05-04 25,000 $3.80 32,693 No 4 P Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Direct
No 4 P Direct
Footnotes
  1. The Reporting Person acquired these shares of common stock in connection with the Issuer's closing of registered direct public offering on May 4, 2022.